Cancer therapy saves lives, but it can also leave a silent, lasting mark on one of the most vulnerable parts of the body: the mouth. Radiation to the head and neck can trigger a rapid, aggressive form of tooth decay, while chemotherapy, radiation and bone-targeting drugs can set the stage for infections and a devastating condition in which portions of the jawbone simply die. For decades, clinicians have known that a thorough dental examination before cancer treatment begins can prevent many of these complications. What has been missing, researchers say, is any standardized way to measure whether dental oncology services are actually delivering that care on time and to a high standard. A new study published in Supportive Care in Cancer now proposes exactly that: a formal quality assurance and quality improvement protocol built specifically for dental oncology, drawing on real-world data from a large cancer centre in Toronto.
The research team, led by Joo Wan James Kim and Erin Watson of the Dental Oncology and Maxillofacial Prosthetics Clinic at Princess Margaret Cancer Centre, part of the University Health Network, in collaboration with colleagues across radiation oncology, medical oncology and blood and marrow transplantation, argues that quality monitoring should be as fundamental to dental oncology as sterilization protocols or radiation safety checklists are elsewhere in medicine. Their work stems from a simple observation: while quality assurance frameworks are well established in surgery, nursing and hospital medicine, no published recommendations exist for systematically tracking the quality of care in dental oncology departments, despite the fact that these services sit on the critical path of cancer treatment for thousands of patients each year.
The clinical stakes are considerable. When tumours in the mouth, throat, neck or surrounding structures are treated with radiation, the salivary glands frequently fall within the treatment field. Reduced saliva flow strips the mouth of its natural buffering and antibacterial defences, and the result can be post-radiation caries, a form of tooth decay so aggressive it can destroy teeth within months of treatment completion. The condition is distinct enough from ordinary decay that the same group previously developed a dedicated measurement tool, the DMFS160 index, to quantify it. Beyond decay, irradiated bone loses much of its capacity to heal. A tooth extraction performed after radiation therapy can fail to heal properly, opening the door to osteoradionecrosis, in which exposed, non-vital jawbone persists and can progress to fracture or chronic infection. Patients receiving high-dose bisphosphonates or other antiresorptive agents for bone metastases or multiple myeloma face a parallel threat, medication-related osteonecrosis of the jaw. Patients undergoing hematopoietic cell transplantation, meanwhile, face immunosuppression, mucositis and bleeding risks that make untreated oral infection genuinely dangerous.
The practical answer, endorsed by consensus guidelines that the Toronto group helped develop for the Canadian dental oncology network, is that every patient should receive a comprehensive dental assessment before radiation therapy, chemotherapy or transplantation begins. Compromised teeth should be restored or, where necessary, extracted with sufficient healing time before treatment starts, and patients should be equipped with customized prevention strategies, including fluoride regimens and oral hygiene protocols, to carry them through a period when their mouths are least able to defend themselves. But guidelines are only as good as their implementation. A clinic may intend to see every head and neck radiation patient within a defined window before treatment; whether it actually does so is a question that can only be answered with data.
That is where the new protocol comes in. Rather than relying on anecdote or retrospective chart review, the researchers designed a prospective quality database that captures structured information on every patient at the initial dental visit. The framework is deliberately divided into four data categories, each answering a different operational and clinical question. The first, Clinic Volume Data, tracks the total number of clinic visits and referrals, providing a measure of demand on the service and, by extension, the staffing and resources required to meet it. The second, Cancer Demographic Data, records the type of cancer and the treatment each patient is receiving, allowing the department to understand its case mix, for example, the proportion of patients referred for head and neck radiation versus those preparing for transplant chemotherapy.
The third category, Clinic Flow Data, is arguably the operational heart of the system. It records three key dates for each patient: the date of referral, the date of the dental consultation and the date of treatment completion. By comparing these timestamps against target intervals, the clinic can quantify delays to care with precision, identifying exactly where in the pathway patients are waiting too long. Because delayed dental clearance can force oncologists to postpone radiation or chemotherapy, these delays are not merely administrative inconveniences; they can directly compromise cancer outcomes. The fourth category, Dental Treatment Data, documents the specific dental treatments provided, from extractions and restorations to preventive interventions, allowing the department to identify trends over time and measure the impact of any changes to its treatment paradigm.
Underpinning the entire system is a quality improvement methodology familiar to hospital administrators but novel in this setting: the Plan-Do-Study-Act cycle, or PDSA. The PDSA approach, popularized in healthcare by improvement scientists and validated in a systematic review published in BMJ Quality and Safety as one of the most widely used frameworks for iterative quality improvement, treats every change to a clinical process as a small-scale experiment. A problem is identified in the planning phase, a modification is implemented on a limited basis, its effects are studied using measured data, and the insight gained informs the next cycle of adjustment. In the dental oncology protocol, the PDSA cycle is driven by a defined data review schedule: the completeness and accuracy of the database are audited monthly, and the full dataset is extracted and analyzed twice a year. Findings from those analyses then feed concrete operational changes.
The study illustrates how this feedback loop works in practice. When Clinic Flow Data revealed delays between referral and consultation or between consultation and the completion of dental treatment, the department responded by adjusting staffing and by redirecting appropriate care to community dental providers, reserving in-house capacity for the most complex and time-sensitive oncology cases. Dental Treatment Data, meanwhile, serves a longer-range scientific purpose: by tracking what treatments are delivered and how treatment patterns shift, the department can evaluate whether changes in radiation techniques, drug protocols or clinical guidelines are translating into changes in dental care needs. The authors note, for example, that radiation planning has increasingly moved toward sparing salivary tissue, and a quality database provides the infrastructure to detect whether such advances reduce the burden of post-radiation dental disease in the patient population actually served.
The remaining two data categories extend the protocol beyond the clinic walls. Clinic Volume Data and Cancer Demographic Data can inform modifications to referral triage, ensuring that the highest-risk patients, such as those scheduled for definitive radiation with multiple failing dentitions, are prioritized appropriately when demand outstrips capacity. These categories also enable reporting at the departmental and institutional level, giving hospital leadership a quantified picture of the dental oncology service’s workload and performance, and they can highlight gaps that warrant formal research. A dataset that consistently shows, say, an unusual concentration of referrals from a particular tumour site or treatment modality immediately suggests a testable hypothesis about where preventive dental care is most needed.
The researchers are careful to frame the protocol as a template rather than a prescription. Because it was developed and is being implemented at a single large academic centre, other departments adopting it would need to adapt the specific data fields, review intervals and response strategies to their own referral patterns, staffing and institutional structures. The framework is also explicitly a quality improvement initiative rather than a clinical trial: the study received ethics approval from the University Health Network’s Quality Improvement Review Committee on the basis that all procedures analysed were part of routine care, and no new experimental interventions were involved. That distinction matters, because it positions the protocol as something any dental oncology service could implement without the barriers of a formal research study, using data it should already be collecting.
What makes the work broadly significant is its underlying philosophy. Quality assurance, in the classic definition borrowed from health services research, is the systematic monitoring of care against explicit standards; quality improvement is the disciplined response when monitoring reveals shortfalls. Both depend on measurement, and measurement depends on structured data captured at the point of care. By specifying exactly which variables matter in dental oncology, from referral timestamps to cancer type to treatments delivered, and by pairing those variables with a proven iterative improvement method, the Toronto team has converted an abstract aspiration, that cancer patients deserve timely, preventive dental care, into a system that can be audited, benchmarked and continuously refined. For a specialty that operates at the intersection of dentistry and life-threatening disease, where a delayed extraction can literally delay cancer treatment, the ability to see and fix bottlenecks in real time may prove as important to patient outcomes as any single clinical technique.
The authors suggest their framework could be adopted not only by dedicated dental oncology departments at comprehensive cancer centres but also by community dental practices that increasingly find themselves treating patients with cancer, whether to provide pre-treatment clearance or long-term management of radiation-related oral disease. As cancer survival rates continue to improve and the population of long-term survivors grows, the oral consequences of curative therapy will be lived with for decades. A system that measures whether those consequences are being prevented, and improves itself when they are not, addresses a need that is only going to expand.
Subject of Research: A standardized quality assurance and quality improvement protocol for dental oncology, using a prospective clinical database and the Plan-Do-Study-Act cycle to monitor and improve dental care for patients undergoing cancer treatment.
Subject of Research: Cancer
Article Title: Quality assurance and improvement in dental oncology
Article References: Kim, J. W. J., Joudah, S., Michaelson, T., Maxymiw, W. G., Yao, C. M. K. L., Hahn, E., Hope, A., Mattsson, J., Chen, C., Hosni, A., Glogauer, M., & Watson, E. (2026). Quality assurance and improvement in dental oncology. Supportive Care in Cancer, 34(9), Article 898. https://doi.org/10.1007/s00520-026-11077-z
Image Credits: AI Generated
DOI: 10.1007/s00520-026-11077-z
Keywords: dental oncology, quality assurance, quality improvement, Plan-Do-Study-Act cycle, post-radiation caries, osteoradionecrosis, head and neck cancer, clinic flow data, dental treatment data, cancer supportive care
Cite Scienmag News
APA MLA Chicago
Nathaniel Bowman. (September 7, 2026). Improving quality assurance standards in dental oncology care. Scienmag. https://scienmag.com/improving-quality-assurance-standards-in-dental-oncology-care/
Nathaniel Bowman. “Improving quality assurance standards in dental oncology care.” Scienmag, 7 September 2026, https://scienmag.com/improving-quality-assurance-standards-in-dental-oncology-care/. Accessed 7 September 2026.
Nathaniel Bowman. “Improving quality assurance standards in dental oncology care.” Scienmag. September 7, 2026. https://scienmag.com/improving-quality-assurance-standards-in-dental-oncology-care/
Copy citation Download RIS
Tags: bone-targeting drugs dental riskscancer therapy oral health managementchemotherapy oral toxicity managementdental oncology quality assurance standardsintegration of dental care in comprehensive cancer treatmentjawbone necrosis in cancer patientsjawbone necrosis prevention strategiesmanagement of chemotherapy-related oral infectionsmultidisciplinary approach in dental oncology caremultidisciplinary approach to oral health in cancer carepatient safety in cancer-related dental procedurespre-treatment dental assessments in oncologypre-treatment dental examination protocolsprevention of radiation-induced tooth decayquality improvement in dental oncology servicesquality improvement protocols for dental oncology servicesradiation-induced oral complications preventionreal-world data for dental oncology quality assessmentreal-world data in dental oncology quality improvementstandardized dental care measurement in cancer patientsstandardized dental care protocols for cancer patientssupporting oral health in cancer treatment patients
